Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001250853-15-000061
Filing Date
2015-06-23
Accepted
2015-06-23 21:08:14
Documents
1
Period of Report
2015-06-19

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 4  
1 PRIMARY DOCUMENT primary_doc.xml 4 4255
  Complete submission text file 0001250853-15-000061.txt   5966
Mailing Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239
Business Address 4640 SW MACADAM AVENUE SUITE 270 PORTLAND OR 97239 855 855 GALE
Galena Biopharma, Inc. (Issuer) CIK: 0001390478 (see all company filings)

EIN.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O GALENA BIOPHARMA, INC. 4640 SW MACADAM AVE, SUITE 270 PORTLAND OR 97239
Business Address
Einhorn Irving M. (Reporting) CIK: 0001603271 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-33958 | Film No.: 15948083